LONDON BROKER RATINGS: JPMorgan cuts M&G, UBS cuts Trainline
(Alliance News) - The following London-listed shares received analyst recommendations on Monday morning and on Friday: Read More
| Price | 633.00p on 02-01-2026 at 08:40:11 |
|---|---|
| Change | 16.00p 2.59% |
| Buy | 635.00p |
| Sell | 631.00p |
| Last Trade: | Sell 192.00 at 633.00p |
| Day's Volume: | 18,967 |
| Last Close: | 617.00p |
| Open: | 620.00p |
| ISIN: | GB00BDFBVT43 |
| Day's Range | 620.00p - 633.00p |
| 52wk Range: | 232.50p - 685.00p |
| Market Capitalisation: | £763.00m |
| VWAP: | 627.03137p |
| Shares in Issue: | 120.54m |
Oxford Biomedica (OXB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 192 | 633.00p | Automatic Execution |
08:35:47 - 02-Jan-26 |
| Sell* | 253 | 633.00p | Automatic Execution |
08:35:47 - 02-Jan-26 |
| Sell* | 170 | 633.00p | Automatic Execution |
08:35:47 - 02-Jan-26 |
| Sell* | 118 | 633.00p | Automatic Execution |
08:35:47 - 02-Jan-26 |
| Sell* | 100 | 633.00p | Automatic Execution |
08:35:47 - 02-Jan-26 |
| Sell* | 256 | 633.20p | Ordinary |
08:35:39 - 02-Jan-26 |
| Buy* | 3 | 634.9948p | Ordinary |
08:35:10 - 02-Jan-26 |
| Sell* | 315 | 633.84p | SI Trade |
08:34:49 - 02-Jan-26 |
| Unknown* | 0 | 635.00p | SI Trade |
08:33:38 - 02-Jan-26 |
| Buy* | 75 | 633.00p | Automatic Execution |
08:33:38 - 02-Jan-26 |
Oxford Biomedica (OXB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 8th Dec 2025 3:15 pm | RNS | PDMR Dealing |
| 1st Dec 2025 7:00 am | RNS | Total Voting Rights |
| 3rd Nov 2025 4:55 pm | RNS | Holding(s) in Company |
| 3rd Nov 2025 7:00 am | RNS | Total Voting Rights |
| 29th Oct 2025 1:59 pm | RNS-R | OXB honoured at 2025 CDMO Leadership Awards Europe |
| 27th Oct 2025 7:00 am | RNS-R | OXB to participate in investor conferences |
| 20th Oct 2025 5:54 pm | RNS | Director/PDMR Shareholding |
| 20th Oct 2025 5:13 pm | RNS | Director/PDMR Shareholding |
| 20th Oct 2025 10:17 am | RNS | Board Change |
| 16th Oct 2025 7:00 am | RNS | Director/PDMR Shareholding |